Diagnosing and managing malignant pleural mesothelioma (MPM) may soon be performed using a simple blood test, a new study suggests, showing ... Read more
The 2016 European Frost & Sullivan Award for Technology Innovation, recognizing excellence in the therapeutic antibody engineering market, was recently awarded to Argenx, a company based ... Read more
Measuring volatile organic compounds (VOCs) by breath analysis is a potent, easy-to-perform technique that can distinguish malignant pleural mesothelioma (MPM) patients from healthy ... Read more
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more